Experienced in Teratocarcinosarcoma

Mansi L. Sharma

Delhi, DL, IN 
Experienced in Teratocarcinosarcoma
Delhi, DL, IN 
OverviewLocationsClinical Research

Overview

Mansi Sharma practices in Delhi, India. Ms. Sharma is rated as an Experienced expert by MediFind in the treatment of Teratocarcinosarcoma. Her top areas of expertise are Tuberculous Uveitis, Recurrent Peripheral Facial Palsy, Melkersson-Rosenthal Syndrome, and Punctate Inner Choroidopathy.

Her clinical research consists of co-authoring 90 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Teratocarcinosarcoma.

Gender
Female

Locations

Delhi, DL, India
Other Locations
New Delhi, DL 110085, India
Rohini, MP, India
Jamnagar, JK, India
Ropar, PB, India
Ropar, BR, India
Bhubaneshwar, OR 751024, India
Patiala, HP, India
Chandigarh, CH 160014, India
Bengaluru, KA, India
Noida, UP 201301, India
Gandhi, UP 110085, India
Greater Noida, UP 201310, India
Mangalore, KA, India
Shimla, HP, India
Mathura, WB, India
Udaipur, HP, India
Hyderabad, TG 500072, India
Dehra Dun, UL 248007, India
Patiala, PB, India
Indore, MP, India
Jamnagar, GJ, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib Following Definitive Locoregional Treatment in Participants With Stage IB-IIIA RET Fusion-Positive NSCLC
LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib Following Definitive Locoregional Treatment in Participants With Stage IB-IIIA RET Fusion-Positive NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: July 24, 2025
Intervention Type: Drug
Study Drug: Selpercatinib
Study Phase: Phase 3

90 Total Publications

First-line pembrolizumab for metastatic NSCLC in lower-middle-income countries: bridging the efficacy-effectiveness gap.
First-line pembrolizumab for metastatic NSCLC in lower-middle-income countries: bridging the efficacy-effectiveness gap.
Journal: Immunotherapy
Published: September 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Sharma's expertise for a condition
ConditionClose
      View All 22 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile